Added to YB: 2023-12-18
Pitch date: 2023-12-18
GPCR [bearish]
Structure Therapeutics Inc.
-86.1%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs in the United States.
Market Cap
$2.2B
Pitch Price
$33.16
Price Target
N/A
Dividend
N/A
EV/EBITDA
-5.94
P/E
-10.08
EV/Sales
N/A
Sector
Pharmaceuticals
Category
N/A
Show full summary:
$GPCR even a better short after falling
$GPCR halved on Ph2a data: GLP-1 pill worse than $LLY's. Bad news, better short now in $30s vs $60s pre-data. Buyout risk down-who wants a less effective, later to market drug?
Read full article (1 min)